FDA Issues Warning on Vision Risks Linked to Popular Weight-Loss Drugs
The U.S. Food and Drug Administration has issued a significant health advisory warning patients and healthcare providers about a rare but serious risk associated with popular GLP-1 weight-loss medications like…